Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey F Barletta

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Critical Care Medicine|February 7, 2025
Pharmacists…Reducing Stress, Optimizing Ulcer ProphylaxisJeffrey F Barletta
Current Opinion in Clinical Nutrition and Metabolic Care|March 9, 2023
Prophylactic acid suppression and enteral nutritionJeffrey F Barletta
Critical Care Medicine|August 17, 2023
Empiric Carbapenem Therapy for Sepsis: Are We Winning the Battle at the Expense of the War?Jeffrey F Barletta
The Annals of Pharmacotherapy|July 2, 2014
Histamine-2-receptor antagonist administration and gastrointestinal bleeding when used for stress ulcer prophylaxis in patients with severe sepsis or septic shockJeffrey F Barletta
Pharmacotherapy|September 8, 2012
Clinical and economic burden of opioid use for postsurgical pain: focus on ventilatory impairment and ileusJeffrey F Barletta
American Journal of Pharmaceutical Education|November 13, 2008
Conducting a successful residency research projectJeffrey F Barletta
Critical Care (London, England)|June 10, 2020
Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and deliriumBrian L Erstad, Jeffrey F Barletta
Critical Care (London, England)|March 15, 2022
Drug dosing in hospitalized obese patients with COVID-19Jeffrey F Barletta, Brian L Erstad
Pharmacotherapy|October 16, 2023
Precision medicine in the ICU: One size fits one patientJeffrey F Barletta, Jason A Roberts
Pharmacoeconomics|November 26, 2013
Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequencesJeffrey F Barletta, David A Sclar
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Critical Care Medicine|February 7, 2025
Pharmacists…Reducing Stress, Optimizing Ulcer ProphylaxisJeffrey F Barletta
Current Opinion in Clinical Nutrition and Metabolic Care|March 9, 2023
Prophylactic acid suppression and enteral nutritionJeffrey F Barletta
Critical Care Medicine|August 17, 2023
Empiric Carbapenem Therapy for Sepsis: Are We Winning the Battle at the Expense of the War?Jeffrey F Barletta
The Annals of Pharmacotherapy|July 2, 2014
Histamine-2-receptor antagonist administration and gastrointestinal bleeding when used for stress ulcer prophylaxis in patients with severe sepsis or septic shockJeffrey F Barletta
Pharmacotherapy|September 8, 2012
Clinical and economic burden of opioid use for postsurgical pain: focus on ventilatory impairment and ileusJeffrey F Barletta
American Journal of Pharmaceutical Education|November 13, 2008
Conducting a successful residency research projectJeffrey F Barletta
Critical Care (London, England)|June 10, 2020
Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and deliriumBrian L Erstad, Jeffrey F Barletta
Critical Care (London, England)|March 15, 2022
Drug dosing in hospitalized obese patients with COVID-19Jeffrey F Barletta, Brian L Erstad
Pharmacotherapy|October 16, 2023
Precision medicine in the ICU: One size fits one patientJeffrey F Barletta, Jason A Roberts
Pharmacoeconomics|November 26, 2013
Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequencesJeffrey F Barletta, David A Sclar
Pageof 11